Malignant hypertension and antiphospholipid antibodies as presenting features of SLE in a young woman using oral contraceptives




Julkunen H, Kaaja R, Jouhikainen T, Teppo AM, Friman C

1991

British Journal of Rheumatology

British journal of rheumatology

Br J Rheumatol

30

6

471

2

2

0263-7103



A 24-year-old woman developed malignant hypertension while on oral contraceptives (OCs). She was found to have incomplete systemic lupus erythematosus (SLE) with DNA antibodies and high levels of antiphospholipid antibodies (APLA). She later developed SLE and has had three miscarriages and a cerebellar infarction.



Last updated on 2024-26-11 at 14:37